Stem Cells and Antibodies in Drug Discovery Europe 2018
Date: May 24 - 25, 2018
Venue: Murray Edwards College, Cambridge, UK

Keynote Speakers

David Hay

David Hay
Professor, University of Edinburgh

Matthew Daniels

Matthew Daniels
Wellcome Trust Intermediate Clinical Fellow, Honorary Consultant Cardiologist, University of Oxford

Gary Gintant

Gary Gintant
Research Fellow, Abbvie


Stem Cells in Drug Discovery 2018 and Antibodies in Drug Discovery 2018 are part of Select Biosciences Innovations in Drug Discovery 2018 Conference Series to be held in Cambridge, UK.

This conference held co-located and concurrently with High-Content & Phenotypic Screening 2018 explores the emerging trends and technologies impacting Drug Discovery, circa 2018.

Stem Cells in Drug Discovery 2018: Hear from and network with researchers who are currently screening for efficacy and toxicity using iPS cell lines, and those responsible for developing the techniques and technologies. There will also be discussions on industry and regulatory developments that are shaping the future of stem cell usage in drug discovery.

Antibodies in Drug Discovery 2018: The focus is to explore the latest developments in the design and engineering of antibodies in relation to the burgeoning field of biotherapeutics. Topics to be addressed include, engineering challenges and techniques, new technologies and business hurdles when developing antibodies, the latest developments in autoimmune and infectious disease research. If you work in antibody drug discovery research you will benefit from the expert knowledge of academic and industry leaders, whilst networking with the technology providers.

Call for Posters

You can also present your research on a poster while attending the meeting.

Poster Submission Deadline: 14 May 2018

Agenda Topics

  • 3D-Cell Based Models
  • Antibodies for New Targets
  • Antibody Drug Conjugates (ADCs)
  • Antibody Screening
  • Humanized Single Domain Antibodies for Research and Therapeutic Applications
  • iPSC-derived Cells for Toxicity Testing & Screening
  • Monoclonal Antibodies
  • Scale Up and Quality Control
  • Screening Technologies, Instrumentation and Reagents
  • Stem Cells in Drug Discovery and Toxicity Screening
  • Targeting Ion Channels with Biologics

Sponsorship and Exhibition Opportunities

Please contact us.

Confirmed Speakers to date

Stefan Dubel, Full Professor and Director, Technische Universitšt Braunschweig
Hua Rong Lu, Senior Principal Scientist, Discovery Sciences, Janssen Pharmaceutical NV

Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks
Choose your language
Traditional Chinese
Simplified Chinese